drugset / Trial / NCT02025439

Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness

NCT02025439

Completed 4 enrolled Edward Hines Jr. VA Hospital
RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.

Timeline

Start
2014-02
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadine Unknown 100 mg
Subject Amantadine Unknown 200 mg